Stocklytics Platform
Asset logo for symbol GEN
Genesis Healthcare
GEN68
$27.63arrow_drop_down0.32%-$0.08
High Quality
S&P500
Asset logo for symbol GEN
GEN68

$27.63

arrow_drop_down0.32%
Key Stats
Open$27.81
Prev. Close$27.72
EPS1.02
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range27.26
27.90
52 Week Range0.00
32.11
Ratios
EPS1.02
Fundamentals
Payout Ratio-
Industry average yield3.25%
Last Dividend pay dateMar 12, 2025
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

GEN-
US Technology Sector-
US Market-
check_circle

GEN / Market

GEN exceeded the US Market which returned -0.68% over the last twenty four hours.
check_circle

GEN / Technology Sector

GEN exceeded the US Technology sector which returned -0.61% over the last twenty four hours.

Genesis Healthcare (GEN) Statistics

Genesis Healthcare Inc. (GEN) is a leading provider of post-acute care services in the United States. The company operates a network of skilled nursing facilities, assisted living centers, and rehabilitation therapy services. With a focus on delivering high-quality care, Genesis Healthcare is committed to improving the health and well-being of its patients and residents. As of the latest financial data, GEN stock has shown some interesting statistics. The stock's current value is $2.50 per share with a market capitalization of $128.6 million. The latest 52-week high for GEN is $6.80, while the 52-week low is $1.65. The stock has a beta value of 1.15, indicating a slightly higher risk compared to the overall market. Over the past year, GEN stock has experienced a significant amount of volatility, with a standard deviation of 1.42.
When it comes to valuation metrics, Genesis Healthcare Inc. has a price to earnings ratio of -0.52, indicating negative earnings. The company's price to sales ratio stands at 0.04, suggesting that each share generates low revenue. In terms of fundamental analysis, GEN has a return on equity of -109.16%, which is quite unfavorable. The company's return on assets is also negative, at -21.64%. These figures indicate that Genesis Healthcare Inc. has been struggling to generate profitability. When comparing the stock's performance to the sector, GEN has underperformed in recent times. The stock's total return over the past year was -61.25%, while the sector's total return was -15.89%. This suggests that investors might have a cautious approach towards GEN in relation to its sector peers.
add Genesis Healthcare  to watchlist

Keep an eye on Genesis Healthcare

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Genesis Healthcare (GEN) stock's performance compared to its sector and the market over the past year?

Over the past year, Genesis Healthcare (GEN) has experienced a price change of . Compared to the Technology sector, which saw a change of 19.05%, Genesis Healthcare has underperformed compared to its sector, indicating its relative standing within the Technology sector. Against the broader market's change of 33.65%, it has fallen short of the market average. This comparison highlights Genesis Healthcare 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Genesis Healthcare (GEN) stock?

The PE (Price to Earnings) ratio of Genesis Healthcare (GEN) is currently 27.09. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Genesis Healthcare (GEN) stock?

The Earnings Per Share (EPS) for Genesis Healthcare (GEN), calculated on a diluted basis, is $1.02. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Genesis Healthcare (GEN) stock?

The operating margin for Genesis Healthcare (GEN) is 41.58%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Genesis Healthcare (GEN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Genesis Healthcare (GEN) is $2.08B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Genesis Healthcare (GEN) have?

Genesis Healthcare (GEN) has a total debt of $8.59B. The net debt, which accounts for cash and cash equivalents against the total debt, is $7.65B.

Take Your Investments to a Whole New Level